Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

Share Price is delayed by 15 minutes
Get Live Data
210.60    3.00 (1.45%)
Bid:
209.80
Ask:
210.20
Spread: 0.40 (0.191%)
Market Cap: £916.68m
KIE Live PriceLast checked at - London Stock Exchange

Intraday Kier Share Chart

Transaction in Own Shares

3 Jul 2025 07:00

RNS Number : 4562P
Kier Group PLC
03 July 2025
Β 

Β 03 July 2025Β Kier Group plcΒ Transaction in Own Shares

KIER GROUP PLC ("Kier", or the "Company") announces that on 02 July 2025 it purchased the following number of its Ordinary shares of 1p each in the Company ("Ordinary Shares") from Peel Hunt LLP as part of the buyback programme announced on 21 January 2025 (the "Buyback Programme").

Date of Purchase

02 July 2025

Aggregate number of Ordinary 1p shares purchased

29,902

Lowest price paid per share (GBp)

205.00

Highest price paid per share (GBp)

205.00

Volume weighted average price paid per share (GBp)

205.00

Broker

PEEL HUNT

Β Kier intends to hold the Ordinary Shares purchased pursuant to the Buyback Programme in Treasury.

Β Following the settlement of the above purchases, Kier has purchased a total of 4,609,672 Ordinary Shares since the commencement of the Buyback Programme and will have 452,875,390 Ordinary Shares of 1 pence each in issue. 4,609,672 Ordinary Shares are held in treasury. The figure 448,265,718 represents the total number of voting rights in Kier and can be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

Β In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as such Regulation has become part of domestic law by virtue of and for the purposes of the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020) and as such Regulation has been amended in such form by any regulations made under that Act), the schedule below contains detailed and aggregated information of the individual trades made by Peel Hunt as part of the buyback programme.

Β This announcement is made in accordance with the requirements of Listing Rule 12.4.6. For further information:

Investor Relations

M: +44 (0)7933 388 746

Kier Press Office

L: +44 (0)1767 355 096

Richard Mountain, FTI Consulting

M: +44 (0)7909 684466

Β Β 

Β Schedule of Purchases - Individual Transactions

Number of shares purchased

Transaction price (GBp)

Venue

Time of transaction

Trade ID

29,902

205.00

XLON

08:21:46

00178961542TRLO0

Β About Kier

Β Kier is a leading UK infrastructure services, construction and property group. We provide specialist design and build capabilities and the knowledge, skills and intellectual capital of our people to ensure we are able to project manage and integrate all aspects of a project.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
POSEAAXAELNSEFA
Date   Source Headline
15th Oct 202111:43 amRNSAnnual Financial Report
5th Oct 202111:04 amRNSDirector/PDMR Shareholding
30th Sep 20219:33 amRNSHolding(s) in Company
21st Sep 20212:17 pmRNSDirector/PDMR Shareholding
20th Sep 20214:52 pmRNSHolding(s) in Company
16th Sep 20217:00 amRNSResults for the year ended 30 June 2021
9th Sep 202111:00 amRNSHolding(s) in Company
2nd Sep 202111:22 amRNSHolding(s) in Company
1st Sep 20218:52 amRNSTotal Voting Rights
31st Aug 20214:07 pmRNSHolding(s) in Company
23rd Aug 20211:05 pmRNSHolding(s) in Company
20th Aug 202110:27 amRNSDirector/PDMR Shareholding
2nd Aug 20219:27 amRNSTotal Voting Rights
23rd Jul 202111:46 amRNSDirector/PDMR Shareholding
23rd Jul 20219:36 amRNSHolding(s) in Company
13th Jul 20217:00 amRNSFull Year 2021 Trading Update
13th Jul 20217:00 amRNSFull Year 2021 Trading Update
1st Jul 20219:05 amRNSBlock listing Interim Review
1st Jul 20218:36 amRNSTotal Voting Rights
25th Jun 20214:41 pmRNSHolding(s) in Company
22nd Jun 20214:05 pmRNSHolding(s) in Company
21st Jun 20213:59 pmRNSDirector/PDMR Shareholding
21st Jun 20212:59 pmRNSHolding(s) in Company
18th Jun 20212:30 pmRNSDirector/PDMR Shareholding
18th Jun 20219:47 amRNSDirector/PDMR Shareholding
18th Jun 20218:30 amRNSHolding(s) in Company
18th Jun 20217:00 amRNSAdmission to trading and notice of trading update
17th Jun 20214:07 pmRNSHolding(s) in Company
16th Jun 202110:17 amRNSResult of Meeting
15th Jun 20218:11 amRNSResult of Open Offer
28th May 20212:56 pmRNSCompletion of the sale of Kier Living
14th May 20214:30 pmRNSDirector/PDMR Shareholding
13th May 20215:36 pmRNSPublication of Prospectus and Notice of GM
13th May 20213:34 pmRNSSuccessful completion of Accelerated Bookbuild
13th May 20217:00 amRNSProposed c.£241 million Capital Raise
7th May 202110:29 amRNSResult of Meeting
5th May 20217:00 amRNSExecutive Appointments
21st Apr 20217:00 amRNSResults for the six months ended 31 December 2020
20th Apr 20215:02 pmRNSNotice of GM
16th Apr 20215:01 pmRNSSale of Kier Living
12th Apr 202111:52 amRNSDirector/PDMR Shareholding
19th Mar 20213:07 pmRNSDirector/PDMR Shareholding
22nd Feb 20214:37 pmRNSDirector/PDMR Shareholding
16th Feb 20216:15 pmRNSDirector Declaration
1st Feb 20217:17 amRNSDirector Declaration
19th Jan 20212:12 pmRNSDirector/PDMR Shareholding
19th Jan 20217:00 amRNSTrading update
13th Jan 20219:04 amRNSBlock listing Interim Review
21st Dec 202012:32 pmRNSDirector/PDMR Shareholding
21st Dec 20207:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.